12 February 2024
With the conditional approval of the Qdenga dengue vaccine, it would be useful for MOH to pilot study the vaccine in dengue hotspots with seroprevalence of over 60% prior to its consideration for the National Immunisation Programme – Dr Musa Mohd Nordin.